Glycaemic control in 163 121 patients with type 2 diabetes on different glucose-lowering treatments: nationwide cross-sectional survey

被引：0
|
作者：
Gudbjornsdottir, S. [1 ]
Miftaraj, M. [2 ]
Svensson, A. -M. [2 ]
Cederholm, J. [3 ]
Ekstrom, N. [1 ]
Zethelius, B. [3 ]
Eliasson, B. [1 ]
机构：
[1] Dept Med, Gothenburg, Sweden
[2] Natl Diabet Register, Gothenburg, Sweden
[3] Dept Publ Hlth & Caring Sci, Uppsala, Sweden
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
376
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [1] Lifestyle Factors Associated with Type 2 Diabetes and Use of Different Glucose-Lowering Drugs: Cross-Sectional Study
    Ulrichsen, Sinna P.
    Mor, Anil
    Svensson, Elisabeth
    Larsen, Finn B.
    Thomsen, Reimar W.
    [J]. PLOS ONE, 2014, 9 (11):
  • [2] Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register
    Ekstrom, N.
    Miftaraj, M.
    Svensson, A. -M.
    Sundell, K. Andersson
    Cederholm, J.
    Zethelius, B.
    Gudbjornsdottir, S.
    Eliasson, B.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (08): : 717 - 726
  • [3] Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey
    Gerber, Philipp Andreas
    Spirk, David
    Braendle, Michael
    Thoenes, Martin
    Lehmann, Roger
    Keller, Ulrich
    [J]. SWISS MEDICAL WEEKLY, 2011, 141
  • [4] Contemporary management of type 2 diabetes: blood glucose-lowering therapies and glycaemic targets
    Davis, Timothy M. E.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2008, 189 (05) : 246 - 248
  • [5] Age disparities in glucose-lowering treatment for Danish people with type 2 diabetes: a cross-sectional study between 2019 and 2020
    Johansson, Karl Sebastian
    Bulow, Cille
    Jimenez-Solem, Espen
    Petersen, Tonny Studsgaard
    Christensen, Mikkel Bring
    [J]. LANCET HEALTHY LONGEVITY, 2023, 4 (12): : E685 - E692
  • [6] Association between Glucose-lowering Treatments and Risk of Diabetic Retinopathy in People with Type 2 Diabetes: A Nationwide Cohort Study
    Jensen, Jakob Hasselstrom
    Vestergaard, Peter
    Jensen, Morten Hasselstrom
    [J]. CURRENT DRUG SAFETY, 2024, 19 (02) : 236 - 243
  • [7] Mechanisms of glucose-lowering effect by rosiglitazone in patients with type 2 diabetes
    Miyazaki, Y
    Matsuda, M
    Mahankali, A
    Mahankali, S
    Cusi, K
    Mandarino, L
    Defronzo, R
    [J]. DIABETES, 2001, 50 : A126 - A127
  • [8] Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
    Prattichizzo, Francesco
    La Sala, Lucia
    Ryden, Lars
    Marx, Nikolaus
    Ferrini, Marc
    Valensi, Paul
    Ceriello, Antonio
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (2_SUPPL) : 73 - 80
  • [9] Factors associated with treatment satisfaction in patients with type 2 diabetes mellitus using oral glucose-lowering agents: a cross-sectional study in urban districts in Japan
    Hayashi, Isao
    Watanabe, Nobuaki
    Nakata, Shinsuke
    Komatsu, Ryoya
    Motode, Saori
    Fujite, Yukari
    Ishibashi, Chisaki
    Baden, Megu Yamaguchi
    Kimura, Takekazu
    Takahara, Mitsuyoshi
    Kozawas, Junji
    Imagawa, Akihisa
    Iwahashi, Hiromi
    Shimomura, Iichiro
    [J]. ENDOCRINE JOURNAL, 2018, 65 (10) : 1001 - 1009
  • [10] Prevalence and determinants of poor glycaemic control: a cross-sectional study among Moroccan type 2 diabetes patients
    Chetoui, Ahmed
    Kaoutar, Kamal
    Elmoussaoui, Soufiane
    Boutahar, Kaltoum
    El Kardoudi, Abdesslam
    Chigr, Fatiha
    Najimi, Mohamed
    [J]. INTERNATIONAL HEALTH, 2022, 14 (04): : 390 - 397
12345